Latest Regulatory Approvals News

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Liontown Resources has raised approximately A$316 million through a combination of institutional and conditional placements, alongside a share purchase plan, to strengthen its balance sheet and support growth at its Kathleen Valley lithium operation.

PointsBet’s board has unanimously recommended shareholders accept MIXI Australia’s increased $1.25 per share cash offer, now unconditional and representing a significant premium. MIXI holds 28.2% of PointsBet and may raise the offer further if it gains majority control.

Magnetite Mines Limited has announced a pro rata renounceable rights issue aiming to raise up to $2.65 million to advance its flagship Razorback iron ore project. The capital raise includes free attaching options and is partially underwritten, supporting key development milestones and strategic partnerships.

Magnetite Mines Limited has announced a renounceable rights issue to raise up to $2.65 million, aiming to fund critical development milestones for its Razorback Iron Ore Project and secure strategic partnerships for DFS funding.

PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.

Piedmont Lithium reported strong Q2 2025 operational results with record production at North American Lithium and $11.9 million revenue, while shareholder voting on its merger with Sayona Mining has been adjourned to August 11.

VRX Silica Limited has secured approval for its Mining Proposal at the Arrowsmith North Silica Sand Project, marking a pivotal step toward production in a globally significant silica sand deposit.

Neometals has agreed to sell its 50% stake in the lithium-ion battery recycling joint venture Primobius to SMS Group for €5 million upfront plus future royalties, marking a strategic pivot away from capital-intensive projects.

The Supreme Court of New South Wales has approved the acquisition scheme for Donaco International by On Nut Road Limited, setting the stage for share suspension and final payment in August 2025.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.